NAMs Menopause Certification Exam 2026
Questions and Answers with complete
solution
Course
NAMS Menopause
1. Which symptom is most characteristic of the menopausal transition?
A. Persistent hypoglycemia
B. Vasomotor symptoms such as hot flashes
C. Progressive anemia in every patient
D. Increased fertility
Answer: B
Complete solution:
Vasomotor symptoms, particularly hot flashes and night sweats, are among the most
characteristic symptoms associated with menopause. They result from changes in
thermoregulatory control associated with fluctuating and ultimately declining ovarian estrogen
production.
2. Menopause is clinically defined as:
A. Six months without menstruation
B. Twelve consecutive months of amenorrhea without another identifiable cause
C. Three months of irregular cycles
D. The first occurrence of a hot flash
Answer: B
Complete solution:
Natural menopause is retrospectively diagnosed after 12 consecutive months without
menstruation when another cause has not been identified. It represents the permanent end of
ovarian follicular activity and reproductive potential.
3. Which hormone generally declines substantially during the menopausal transition?
,A. Estrogen
B. Insulin
C. Cortisol
D. Growth hormone only
Answer: A
Complete solution:
Ovarian estrogen production declines substantially as ovarian follicular activity decreases.
Hormonal fluctuations can begin during perimenopause before estrogen levels ultimately
become consistently lower after menopause.
4. A 49-year-old reports irregular menstrual cycles and intermittent hot flashes. Which stage is
most consistent with these findings?
A. Postmenopause
B. Perimenopause/menopausal transition
C. Childhood
D. Premature ovarian failure in every case
Answer: B
Complete solution:
Perimenopause, also called the menopausal transition, commonly involves changing menstrual
patterns and vasomotor symptoms. Menstrual irregularity often precedes the final menstrual
period.
5. Which symptom is classified as a vasomotor symptom?
A. Hot flash
B. Vaginal dryness
C. Dysuria
D. Joint deformity
Answer: A
Complete solution:
Hot flashes and night sweats are vasomotor symptoms. Genitourinary symptoms, such as
vaginal dryness and urinary discomfort, belong to the genitourinary syndrome of menopause
rather than the vasomotor category.
,6. A patient reports severe hot flashes that interfere with sleep and work. What is the most
appropriate initial approach?
A. Tell the patient that treatment is unnecessary
B. Assess symptom severity, medical history, preferences, contraindications, and treatment
goals
C. Automatically prescribe systemic hormone therapy
D. Recommend stopping all medications
Answer: B
Complete solution:
Management should be individualized. Assessment should include symptom burden, health
history, risk factors, medications, preferences, and whether hormonal or nonhormonal
treatment is appropriate.
7. Which statement about menopausal hormone therapy (MHT) is most accurate?
A. It is appropriate for every postmenopausal patient
B. It can be an effective treatment for bothersome vasomotor symptoms in appropriately
selected patients
C. It should never be used after menopause
D. It is primarily prescribed to prevent wrinkles
Answer: B
Complete solution:
MHT is one of the most effective treatments for bothersome vasomotor symptoms in
appropriately selected patients. Individual benefits and risks must be evaluated before
treatment.
8. A patient with an intact uterus is considering systemic estrogen therapy. Why is a
progestogen generally included?
A. To increase ovarian estrogen production
B. To reduce the risk of estrogen-induced endometrial hyperplasia and cancer
C. To prevent all breast cancer
D. To eliminate hot flashes immediately
, Answer: B
Complete solution:
Systemic estrogen stimulates the endometrium. In patients with an intact uterus, adequate
progestogen exposure is generally used with systemic estrogen to provide endometrial
protection.
9. Which patient generally does NOT require a progestogen solely for endometrial protection
when receiving systemic estrogen?
A. Patient with an intact uterus
B. Patient who has undergone total hysterectomy
C. Patient with unexplained uterine bleeding
D. Patient with an endometrial disorder
Answer: B
Complete solution:
After a total hysterectomy, there is generally no endometrium requiring protection. Exceptions
and individual clinical circumstances should still be considered.
10. Which route of estrogen administration bypasses first-pass hepatic metabolism?
A. Oral
B. Transdermal
C. Sublingual vitamin tablet
D. Oral calcium
Answer: B
Complete solution:
Transdermal estrogen is absorbed through the skin and avoids the initial hepatic first-pass effect
associated with oral administration. Route selection should be individualized based on patient
characteristics and preferences.
11. A patient primarily has vaginal dryness and dyspareunia related to menopause without
significant systemic symptoms. Which treatment may be particularly appropriate?
A. Local low-dose vaginal estrogen
B. High-dose systemic estrogen for every patient
Questions and Answers with complete
solution
Course
NAMS Menopause
1. Which symptom is most characteristic of the menopausal transition?
A. Persistent hypoglycemia
B. Vasomotor symptoms such as hot flashes
C. Progressive anemia in every patient
D. Increased fertility
Answer: B
Complete solution:
Vasomotor symptoms, particularly hot flashes and night sweats, are among the most
characteristic symptoms associated with menopause. They result from changes in
thermoregulatory control associated with fluctuating and ultimately declining ovarian estrogen
production.
2. Menopause is clinically defined as:
A. Six months without menstruation
B. Twelve consecutive months of amenorrhea without another identifiable cause
C. Three months of irregular cycles
D. The first occurrence of a hot flash
Answer: B
Complete solution:
Natural menopause is retrospectively diagnosed after 12 consecutive months without
menstruation when another cause has not been identified. It represents the permanent end of
ovarian follicular activity and reproductive potential.
3. Which hormone generally declines substantially during the menopausal transition?
,A. Estrogen
B. Insulin
C. Cortisol
D. Growth hormone only
Answer: A
Complete solution:
Ovarian estrogen production declines substantially as ovarian follicular activity decreases.
Hormonal fluctuations can begin during perimenopause before estrogen levels ultimately
become consistently lower after menopause.
4. A 49-year-old reports irregular menstrual cycles and intermittent hot flashes. Which stage is
most consistent with these findings?
A. Postmenopause
B. Perimenopause/menopausal transition
C. Childhood
D. Premature ovarian failure in every case
Answer: B
Complete solution:
Perimenopause, also called the menopausal transition, commonly involves changing menstrual
patterns and vasomotor symptoms. Menstrual irregularity often precedes the final menstrual
period.
5. Which symptom is classified as a vasomotor symptom?
A. Hot flash
B. Vaginal dryness
C. Dysuria
D. Joint deformity
Answer: A
Complete solution:
Hot flashes and night sweats are vasomotor symptoms. Genitourinary symptoms, such as
vaginal dryness and urinary discomfort, belong to the genitourinary syndrome of menopause
rather than the vasomotor category.
,6. A patient reports severe hot flashes that interfere with sleep and work. What is the most
appropriate initial approach?
A. Tell the patient that treatment is unnecessary
B. Assess symptom severity, medical history, preferences, contraindications, and treatment
goals
C. Automatically prescribe systemic hormone therapy
D. Recommend stopping all medications
Answer: B
Complete solution:
Management should be individualized. Assessment should include symptom burden, health
history, risk factors, medications, preferences, and whether hormonal or nonhormonal
treatment is appropriate.
7. Which statement about menopausal hormone therapy (MHT) is most accurate?
A. It is appropriate for every postmenopausal patient
B. It can be an effective treatment for bothersome vasomotor symptoms in appropriately
selected patients
C. It should never be used after menopause
D. It is primarily prescribed to prevent wrinkles
Answer: B
Complete solution:
MHT is one of the most effective treatments for bothersome vasomotor symptoms in
appropriately selected patients. Individual benefits and risks must be evaluated before
treatment.
8. A patient with an intact uterus is considering systemic estrogen therapy. Why is a
progestogen generally included?
A. To increase ovarian estrogen production
B. To reduce the risk of estrogen-induced endometrial hyperplasia and cancer
C. To prevent all breast cancer
D. To eliminate hot flashes immediately
, Answer: B
Complete solution:
Systemic estrogen stimulates the endometrium. In patients with an intact uterus, adequate
progestogen exposure is generally used with systemic estrogen to provide endometrial
protection.
9. Which patient generally does NOT require a progestogen solely for endometrial protection
when receiving systemic estrogen?
A. Patient with an intact uterus
B. Patient who has undergone total hysterectomy
C. Patient with unexplained uterine bleeding
D. Patient with an endometrial disorder
Answer: B
Complete solution:
After a total hysterectomy, there is generally no endometrium requiring protection. Exceptions
and individual clinical circumstances should still be considered.
10. Which route of estrogen administration bypasses first-pass hepatic metabolism?
A. Oral
B. Transdermal
C. Sublingual vitamin tablet
D. Oral calcium
Answer: B
Complete solution:
Transdermal estrogen is absorbed through the skin and avoids the initial hepatic first-pass effect
associated with oral administration. Route selection should be individualized based on patient
characteristics and preferences.
11. A patient primarily has vaginal dryness and dyspareunia related to menopause without
significant systemic symptoms. Which treatment may be particularly appropriate?
A. Local low-dose vaginal estrogen
B. High-dose systemic estrogen for every patient
